These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24867785)

  • 21. Reply to Soman et al and Frippiat et al.
    Falagas ME; Tansarli GS; Ikawa K; Vardakas KZ
    Clin Infect Dis; 2013 Jul; 57(2):325-7. PubMed ID: 23547167
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of ertapenem use in critical state patients].
    Beloborodov VB
    Antibiot Khimioter; 2011; 56(3-4):10-2, 14-6. PubMed ID: 21913404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.
    Udy AA; Dulhunty JM; Roberts JA; Davis JS; Webb SAR; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J; ;
    Int J Antimicrob Agents; 2017 May; 49(5):624-630. PubMed ID: 28286115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    Sauermann R; Burian B; Burian A; Jäger W; Höferl M; Stella A; Theurer S; Riedl M; Zeitlinger M
    J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics in the critically ill: the bug, drug, host triad.
    Shorr AF
    Chest; 2012 Jul; 142(1):8-10. PubMed ID: 22796830
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibiotic dosing in the critically ill: asking the same questions but expecting different answers.
    Póvoa P; Spriet I; Zahar JR
    Intensive Care Med; 2014 Nov; 40(11):1780-2. PubMed ID: 25246088
    [No Abstract]   [Full Text] [Related]  

  • 27. Who should receive extended infusion beta-lactam therapy?
    Roman C; Solh T; Damer KM
    JAAPA; 2016 Mar; 29(3):25-6. PubMed ID: 26914778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
    Roberts JA; Ulldemolins M; Roberts MS; McWhinney B; Ungerer J; Paterson DL; Lipman J
    Int J Antimicrob Agents; 2010 Oct; 36(4):332-9. PubMed ID: 20685085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
    Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
    Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibiotics and overweight].
    Madsen H; Brøsen K; Frimodt-Møller N; Gahrn-Hansen B
    Ugeskr Laeger; 2005 May; 167(21):2266-70. PubMed ID: 15962851
    [No Abstract]   [Full Text] [Related]  

  • 31. Subtherapeutic beta-lactam plasma concentrations in critically ill burned patients in the era of continuous intravenous administration.
    Duputié G; Darrouzain F; Forme N; Cohen B; Rémérand F; Miguel Montanes R
    Burns; 2024 Jun; 50(5):1352-1354. PubMed ID: 38494396
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic drug monitoring of beta-lactam antibiotics in burns patients--a one-year prospective study.
    Patel BM; Paratz J; See NC; Muller MJ; Rudd M; Paterson D; Briscoe SE; Ungerer J; McWhinney BC; Lipman J; Roberts JA
    Ther Drug Monit; 2012 Apr; 34(2):160-4. PubMed ID: 22406650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-lactam antibiotics].
    Suárez C; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization.
    Sime FB; Udy AA; Roberts JA
    Curr Opin Pharmacol; 2015 Oct; 24():1-6. PubMed ID: 26119486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis.
    Lee YR; Miller PD; Alzghari SK; Blanco DD; Hager JD; Kuntz KS
    Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):155-170. PubMed ID: 29027128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous infusion of beta-lactam antibiotics to treat severe sepsis: a waste of time or worth the hassle?
    Dunning J; Roberts J
    Br J Hosp Med (Lond); 2015 May; 76(5):310. PubMed ID: 25959950
    [No Abstract]   [Full Text] [Related]  

  • 37. Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.
    Rizk NA; Kanafani ZA; Tabaja HZ; Kanj SS
    Expert Rev Anti Infect Ther; 2017 Jul; 15(7):645-652. PubMed ID: 28657373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.
    Brink AJ; Richards GA; Schillack V; Kiem S; Schentag J
    Int J Antimicrob Agents; 2009 May; 33(5):432-6. PubMed ID: 19091521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral beta-lactams in the treatment of acute bacterial rhinosinusitis.
    Hadley JA; Pfaller MA
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):47S-54S. PubMed ID: 17292580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Part II. Introduction to the beta-lactam antibiotics.
    Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.